Showing results (871-880 of 3,636) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|June 23, 2021
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysisDaniel Reinhorn, Raz Mutai, Rinat Yerushalmi, et al.Breast (Edinburgh, Scotland)|June 24, 2021
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrialsMonika Graeser, Nadia Harbeck, Oleg Gluz, et al.Breast (Edinburgh, Scotland)|December 31, 2022
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter studyJingtong Zhai, Xiaoying Sun, Fang Zhao, et al.Breast (Edinburgh, Scotland)|January 1, 2023
Hyperbaric oxygen therapy for local late radiation toxicity in breast cancer patients: A systematic reviewE L Meier, D R Mink van der Molen, C A Lansdorp, et al.Breast (Edinburgh, Scotland)|December 19, 2022
Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancerShuling Zhou, Ting Liu, Xiaying Kuang, et al.Breast (Edinburgh, Scotland)|June 21, 2022
Breast cancer patients' most important quality of life themes for a radiotherapy decision aidCheryl Roumen, Hajar Hasannejadasl, Rachelle Swart, et al.Breast (Edinburgh, Scotland)|December 3, 2022
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up studyJavier García-Sánchez, Mayra Alejandra Mafla-España, María Dolores Torregrosa, et al.Breast (Edinburgh, Scotland)|December 4, 2022
Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapyPan Gong, Guyu Dai, Xiaoyu Wu, et al.Breast (Edinburgh, Scotland)|December 4, 2022
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3Hope S Rugo, Seock-Ah Im, Anil A Joy, et al.Breast (Edinburgh, Scotland)|June 11, 2022
Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistryC F Singer, S W Jahn, M Rudas, et al.Pageof 364